Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.1 USD | -1.27% | -9.50% | -74.26% |
Apr. 23 | Biohaven Shares Rise After Closing of Public Offering, Disclosure of Stock Purchase by CEO | MT |
Apr. 23 | UBS Adjusts Biohaven Price Target to $60 From $59, Maintains Buy Rating | MT |
- Stock Market
- Equities
- BHVN Stock
- News Biohaven Pharmaceutical Holding Company Ltd.